| Stage | CEG | % of rev | EXC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.5B | 100.00% | $7.2B | 100.00% | CEG ×1.04 |
| Gross profit | $3.5B | 46.39% | $3.0B | 41.43% | CEG +5.0pp |
| Operating income | $580M | 7.73% | $1.6B | 22.16% | EXC +14.4pp |
| Pre-tax income | $900M | 11.99% | $1.1B | 15.45% | EXC +3.5pp |
| Net income | $508M | 6.77% | $919M | 12.69% | EXC +5.9pp |
| Stage | CEG | EXC | Gap · A − B |
|---|---|---|---|
| Revenue | $7.5B100.00% | $7.2B100.00% | CEG ×1.04 |
| Gross profit | 46.39%$3.5B | 41.43%$3.0B | CEG +5.0pp |
| Operating income | 7.73%$580M | 22.16%$1.6B | EXC +14.4pp |
| Pre-tax income | 11.99%$900M | 15.45%$1.1B | EXC +3.5pp |
| Net income |
| 6.77%$508M |
| 12.69%$919M |
| EXC +5.9pp |